One of our previous studies in NPC had shed a light on the relationship between the serum CCL2 (sCCL2) level of patients and their prognosis, suggesting that high sCCL2 level predicts bone invasion, post-treatment distant metastasis and poor overall survival in NPC patients [23]. This evidence concerns the gene CCL2 and nasopharyngeal carcinoma.